← Open Payments lookup

AUNJEL FAUCHEUX: Open Payments

NPI 1194232330 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$849 in 49 payments from 14 companies in 2025. Trend: 2023 $1,126 · 2024 $1,869 · 2025 $849

Food & beverage: $849
CompanyPaymentsAmount
Novo Nordisk Inc13$179
Lilly USA, LLC5$175
ABBVIE INC.12$139
GlaxoSmithKline, LLC.5$94
Otsuka America Pharmaceutical, Inc.3$51
Merck Sharp & Dohme LLC2$30
Phathom Pharmaceuticals, Inc.2$27
Bayer Healthcare Pharmaceuticals Inc.1$26
Abbott Laboratories1$25
Astellas Pharma US Inc1$24

Products named: ZEPBOUND, VRAYLAR, Ozempic, SHINGRIX, MOUNJARO, REXULTI, Wegovy, Rybelsus.

Industry payments across LA — which companies pay providers there.